Author Page for Lene Kristin Brekke

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Exploring Drug Cost and Disease Outcome in Rheumatoid Arthritis Patients Treated With Biologic and Targeted Synthetic DMARDs in Norway from 2010 to 2019 – A Country With a National Tender System for Prescription of Costly Drugs

Number of pages: 29 Posted: 18 Aug 2021

Alen Brkic, Andreas P. Diamantopoulos, Espen Andre Haavardsholm, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke, Liz Loli, Camilla Zettel, Erik Rødevand, Gunnstein Bakland, Pawel Mielnik and Glenn Haugeberg

Sorlandet Hospital - Research Department, Martina Hansen Hospital - Department of Rheumatology, Diakonhjemmet Hospital - Division of Rheumatology and Research, University of Bergen - Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease, Haugesund Hospital for Rheumatic Diseases, Lillehammer Hospital for Rheumatic Diseases, Betanien Hospital - Department of Rheumatology, Trondheim University Hospital - Department of Rheumatology, University Hospital of North Norway - Department of Rheumatology, District General Hospital of Førde - Section for Rheumatology and Sorlandet Hospital - Research Department

Downloads 51 (1,052,702)

Lene Kristin Brekke

Haugesund Hospital for Rheumatic Diseases

1

51

0

Scholarly Papers (1)

Exploring Drug Cost and Disease Outcome in Rheumatoid Arthritis Patients Treated With Biologic and Targeted Synthetic DMARDs in Norway from 2010 to 2019 – A Country With a National Tender System for Prescription of Costly Drugs

Abstract: